-+ 0.00%
-+ 0.00%
-+ 0.00%

Wells Fargo Maintains Overweight on Metagenomi, Lowers Price Target to $20

Benzinga·03/18/2025 12:48:21
Listen to the news
Wells Fargo analyst Yanan Zhu maintains Metagenomi (NASDAQ:MGX) with a Overweight and lowers the price target from $25 to $20.